Matthew Hellmann
MD
Attending Physician, Thoracic Oncology Service
👥Biography 个人简介
Matthew Hellmann is a leading thoracic oncology immunotherapy researcher who has contributed to TIGIT-targeting clinical trials and tumor mutational burden as a predictive biomarker. His work on combination checkpoint strategies in NSCLC has defined the landscape of next-generation immunotherapy. He has been influential in understanding why some TIGIT combinations have shown mixed clinical results.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Hellmann 的研究动态
Follow Matthew Hellmann's research updates
留下邮箱，当我们发布与 Matthew Hellmann（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment